About CLAREO BIOSCIENCES, INC.
Clareo Biosciences enables precision therapeutic development based on immune receptor diversity for labs and clinics worldwide by leveraging immune profiling data to improve diagnoses and design more effective treatments and vaccines.
Complete and precise immune repertoire sequencingAccurate discrimination of antibody and TCR-encoding genes and allelesCharacterization of antigen-associated clonal lineages, binding domains, and somatic hypermutation profilesLinking effector function and antigen binding domains with resolution of antibody isotype/subisotype and constant domain allelic variationHigh-resolution immune receptor gene curation with novel gene and allele discoveryComplete genotyping of functional coding and non-coding single nucleotide variants and large gene insertions and deletions
Is this your company?
Claim CLAREO BIOSCIENCES, INC. to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim CLAREO BIOSCIENCES, INC. & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.